CIK: 0001674712 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 16, 2021
Total Value ($000): $2,310,071 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Instil Bio Inc | 12,486,787 | $241,245 | 10.4% | $25.08 | — | Common | 45783C101 |
| ALXO | ALX Oncology Holdings Inc | 4,220,048 | $230,752 | 10.0% | $39.31 | +52.2% | Common | 00166B105 |
| ASND | Ascendis Pharma A/S | 1,526,359 | $200,793 | 8.7% | $112.61 | — | SPONSORED ADR | 04351P101 |
| — | Amyris, Inc | 11,639,929 | $190,546 | 8.2% | $3.12 | — | Common | 03236M200 |
| — | New Frontier Health Corp | 14,300,000 | $159,731 | 6.9% | $8.25 | — | Ord Shs | G6461G106 |
| HRMY | Harmony Biosciences Holdings Inc | 4,534,341 | $128,004 | 5.5% | $36.46 | -17.7% | Common | 413197104 |
| — | Genetron Holdings Ltd | 6,339,860 | $127,685 | 5.5% | $12.07 | — | ADS | 37186H100 |
| TARS | Tarsus Pharmaceuticals Inc | 2,987,331 | $86,573 | 3.7% | $28.48 | +9.6% | Common | 87650L103 |
| — | Aligos Therapeutics Inc | 3,547,030 | $72,306 | 3.1% | $27.65 | — | Common | 01626L105 |
| — | Bolt Therapeutics Inc | 3,871,291 | $59,850 | 2.6% | $32.91 | — | Common | 097702104 |
| KALV | KalVista Pharmaceuticals Inc. | 1,863,296 | $44,645 | 1.9% | $15.45 | +69.3% | Common | 483497103 |
| — | Essa Pharma Inc | 1,551,680 | $44,331 | 1.9% | $9.69 | — | Common | 29668H708 |
| LEGN | Legend Biotech Corp Sponsored | 956,702 | $39,273 | 1.7% | $42.56 | — | SPONSORED ADS | 52490G102 |
| SVA | Sinovac Biotech Ltd. | 5,900,000 | $38,173 | 1.7% | $6.47 | 0.0% | SHS | P8696W104 |
| — | Iveric Bio Inc | 5,966,527 | $37,649 | 1.6% | $5.10 | — | Common | 46583P102 |
| — | Sierra Oncology, Inc | 1,917,074 | $37,325 | 1.6% | $10.67 | — | Common | 82640U404 |
| OLMA | Olema Pharmaceuticals Inc | 1,238,575 | $34,655 | 1.5% | $46.89 | -39.3% | Common | 68062P106 |
| CRNX | Crinetics Pharmaceuticals Inc | 1,752,346 | $33,032 | 1.4% | $20.29 | -13.4% | Common | 22663K107 |
| TERN | Terns Pharmaceuticals Inc | 2,675,133 | $32,797 | 1.4% | $21.92 | -22.3% | Common | 880881107 |
| CLDX | Celldex Therapeutics Inc | 968,906 | $32,400 | 1.4% | $4.95 | +454.6% | Common | 15117B202 |
| ZLAB | Zai Lab Ltd ADR | 175,000 | $30,973 | 1.3% | $76.83 | — | ADR | 98887Q104 |
| — | Impel NeuroPharma Inc | 2,884,789 | $25,530 | 1.1% | $8.85 | — | Common | 45258K109 |
| ACRS | Aclaris Therapeutics, Inc. | 1,374,279 | $24,132 | 1.0% | $1.36 | +1568.7% | Common | 00461U105 |
| — | Kadmon Holdings Inc | 5,817,459 | $22,514 | 1.0% | $4.19 | — | Common | 48283N106 |
| — | Verona Pharma PLC ADR | 3,048,507 | $19,937 | 0.9% | $5.20 | — | ADS | 925050106 |
| — | Avadel Pharmaceuticals PLC | 2,937,093 | $19,767 | 0.9% | $7.94 | — | ADR | 05337M104 |
| NVAX | Novavax Inc | 88,046 | $18,693 | 0.8% | $121.82 | +50.4% | Common | 670002401 |
| — | Gracell Biotechnologies Inc | 1,328,257 | $17,267 | 0.7% | $15.40 | — | SPONSORED ADS | 38406L103 |
| NKTX | Nkarta Inc | 512,225 | $16,232 | 0.7% | $29.47 | -2.2% | Common | 65487U108 |
| — | Eiger BioPharmaceuticals Inc | 1,791,257 | $15,262 | 0.7% | $6.80 | — | Common | 28249U105 |
| CYTK | Cytokinetics Inc | 700,000 | $13,853 | 0.6% | $23.39 | +0.4% | Common | 23282W605 |
| MREO | Mereo Biopharma Group PLC | 4,220,938 | $13,380 | 0.6% | $2.68 | — | ADS | 589492107 |
| — | Curis Inc | 1,553,500 | $12,537 | 0.5% | $8.50 | — | Common | 231269200 |
| — | Chinook Therapeutics Inc | 872,151 | $12,315 | 0.5% | $15.86 | — | Common | 16961L106 |
| DYN | Dyne Therapeutics Inc | 577,642 | $12,154 | 0.5% | $20.78 | -9.5% | Common | 26818M108 |
| ARQT | Arcutis Biotherapeutics Inc | 433,585 | $11,833 | 0.5% | $26.87 | +4.8% | Common | 03969K108 |
| ARWR | Arrowhead Pharmaceuticals Inc | 137,411 | $11,380 | 0.5% | $40.33 | +84.6% | Common | 04280A100 |
| KURA | Kura Oncology Inc | 525,262 | $10,952 | 0.5% | $14.42 | +72.1% | Common | 50127T109 |
| DSGN | Design Therapeutics | 530,991 | $10,561 | 0.5% | $31.14 | -19.0% | Common | 25056L103 |
| VALN | Valneva SE | 400,000 | $10,540 | 0.5% | $26.35 | — | SPONSORED ADS | 92025Y103 |
| — | Zymeworks Inc | 286,064 | $9,924 | 0.4% | $35.47 | — | Common | 98985W102 |
| — | Aslan Pharmaceuticals Ltd | 2,840,909 | $9,375 | 0.4% | $3.35 | — | ADS | 04522R101 |
| — | Merus NV | 442,000 | $9,313 | 0.4% | $21.00 | — | Common | N5749R100 |
| CDXS | Codexis, Inc | 388,144 | $8,795 | 0.4% | $13.98 | +55.0% | Common | 192005106 |
| — | Satsuma Pharmaceuticals Inc | 1,232,394 | $8,688 | 0.4% | $5.91 | — | Common | 80405P107 |
| — | Passage Bio Inc | 646,001 | $8,553 | 0.4% | $15.75 | — | Common | 702712100 |
| LRMR | Larimar Therapeutics Inc | 799,662 | $7,853 | 0.3% | $11.65 | -3.0% | Common | 517125100 |
| — | Elevation Oncology Inc | 496,843 | $6,742 | 0.3% | $13.57 | — | Common | 28623U101 |
| AUPH | Aurinia Pharmaceuticals Inc. | 500,732 | $6,489 | 0.3% | $17.64 | -27.8% | Common | 05156V102 |
| — | Homology Medicines, Inc. | 853,143 | $6,202 | 0.3% | $15.54 | — | Common | 438083107 |
| — | Orchard Therapeutics plc | 1,325,736 | $5,820 | 0.3% | $7.53 | — | ADS | 68570P101 |
| IMVT | Immunovant Inc | 532,847 | $5,632 | 0.2% | $24.46 | -42.9% | Common | 45258J102 |
| SNDX | Syndax Pharmaceuticals Inc | 320,000 | $5,494 | 0.2% | $22.59 | -18.9% | Common | 87164F105 |
| TXG | 10X Genomics Inc | 14,798 | $2,898 | 0.1% | $145.11 | +24.7% | CL A Common | 88025U109 |
| — | Calliditas Therapeutics ADR | 62,306 | $1,835 | 0.1% | $23.20 | — | SPONSORED ADS | 13124Q106 |
| — | Zogenix Inc | 105,000 | $1,814 | 0.1% | $22.77 | — | Common | 98978L204 |
| — | Precision Biosciences Inc | 140,255 | $1,756 | 0.1% | $6.03 | — | Common | 74019P108 |
| — | Tricida, Inc. | 174,763 | $755 | 0.0% | $22.00 | — | Common | 89610F101 |
| — | Metacrine Inc | 146,426 | $556 | 0.0% | $10.21 | — | Common | 59101E103 |